Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance
Open Access
Abstract
Pancreatic cancer (PaC) is one of the most lethal tumors worldwide, difficult to diagnose, and with inadequate therapeutical chances. The most used therapy is gemcitabine, alone or in combination with nanoparticle albumin-bound paclitaxel (nab-paclitaxel), and the multidrug FOLFIRINOX. Unfortunately, PaC develops resistance early, thus reducing the already poor life expectancy of patients. The mechanisms responsible for drug resistance are not fully elucidated, and exosomes seem to be actively involved in this phenomenon, thanks to their ability to transfer molecules regulating this process from drug-resistant to drug-sensitive PaC cells. These extracellular vesicles are released by both normal and cancer cells and seem to be essential mediators of intercellular communications, especially in cancer, where they are secreted at very high numbers. This review illustrates the role of exosomes in PaC drug resistance. This manuscript first provides an overview of the pharmacological approaches used in PaC and, in the last part, focuses on the mechanisms exploited by the exosomes released by cancer cells to induce drug resistance.Keywords
Funding Information
- Italian Ministry of University and Scientific Research (P.R.I.N. 2017EKMFTN_002, Progetto di Ricerca Finalizzata RF—2019—12368937, PATG.Rice.Base.GiovaniRicercatori2022.IDEA)
- Regione Sicilia (P.R.I.N. 2017EKMFTN_002, Progetto di Ricerca Finalizzata RF—2019—12368937, PATG.Rice.Base.GiovaniRicercatori2022.IDEA)
- Vanvitelli Young Researcher (P.R.I.N. 2017EKMFTN_002, Progetto di Ricerca Finalizzata RF—2019—12368937, PATG.Rice.Base.GiovaniRicercatori2022.IDEA)
This publication has 85 references indexed in Scilit:
- Diabetes and pancreatic cancerEndocrine-Related Cancer, 2012
- The Genomic and Proteomic Content of Cancer Cell-Derived ExosomesFrontiers in Oncology, 2012
- Diabetes and pancreatic cancerMolecular Carcinogenesis, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapyBritish Journal of Cancer, 2010
- Interplay of proteins and lipids in generating membrane curvatureCurrent Opinion in Cell Biology, 2010
- Cellular Internalization of Exosomes Occurs Through PhagocytosisTraffic, 2010
- Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potentialBritish Journal of Cancer, 2009
- The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.Journal of Clinical Investigation, 1998
- The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell linesCancer Letters, 1996